Hepatic late adverse effects after antineoplastic treatment for childhood cancer - Wikidata - wikimedia - TriplyDB

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

http://www.wikidata.org/entity/Q24235525

about

Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer Examining the Distribution, Modularity, and Community Structure in Article Networks for Systematic Reviews Iron overload in children undergoing cancer treatments.Severe fatigue in childhood cancer survivors

P2860

Q24197545-9960EE05-020C-4017-9672-C16A1DA1EEF8 Q38614794-78685F2C-D67F-454B-B03C-033B6530B3A5 Q44719860-DF9DD0A0-9258-4C0B-A79A-2F17E16C1C82 Q57253224-B7A442E1-BBA6-4CC0-8564-EF5A945836BC

P2860

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

http://www.wikidata.org/entity/Q24235525

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@ast

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@en

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@en-gb

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@nl

type

label

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@ast

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@en

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@en-gb

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@nl

prefLabel

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@ast

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@en

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@en-gb

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@nl

P1433

Q24235525-E4473DB4-6244-45C2-A767-961BA2DD0AE4

P1476

Q24235525-986ED838-B349-4E5F-8D55-BB1016BEF013

P2093

Q24235525-3535F09B-8274-4153-BB52-08B7D1F7419C

Q24235525-438902BE-E3A1-46EB-8400-C8A46B6CF76F

Q24235525-4DE2481E-4D53-407D-A240-AE56B1072277

Q24235525-5B4333BF-1849-409F-BBBD-EB6F59C1AC06

Q24235525-78F0EF2E-1D68-4CD2-8366-515290672D69

Q24235525-92695B2E-E8A4-44C8-9EFE-1610DFE23071

Q24235525-98E0AF9A-B2F1-4274-95AD-DDCA55F4F08A

Q24235525-9B99FBEA-FC18-449F-8D7E-D612D6070064

Q24235525-9ED74A7E-18DE-4DA8-8949-3DD61E3D1157

Q24235525-AC90577F-921F-4FBF-BE41-8DB25233AA37

P2860

Q24235525-05571A56-6E5B-4F15-8EA1-200CE737449F

Q24235525-05DB8D00-117E-4723-8CF2-2F443E11A81E

Q24235525-05EB6187-327A-4ECB-80DD-252F36581963

Q24235525-06B01ACF-B976-4760-8EB5-F6850AE9709E

Q24235525-084F75A6-A191-493D-96FC-6D2E0FF29955

Q24235525-13F87A59-E23C-4978-B6CA-4DAB7F758B6B

Q24235525-163CA6EA-4347-4FCE-A387-17B3F864FA17

Q24235525-1E24B2DA-C20F-420C-A970-0AE5DFC99D3E

Q24235525-1EC3E07B-8C13-4AFE-AD33-A72B91EA47B5

Q24235525-1EC93D70-23B1-4794-84D0-2C55BB646A5D

P304

Q24235525-6BE1A822-A6ED-4F81-93AB-37C6DE09C06A

P31

Q24235525-E4753085-581A-4374-A83F-0304AD7EEB59

Q24235525-d5c7430e-076c-44c3-8c0f-d6340e718b73

P356

Q24235525-FB94F8F4-7EC9-4C57-84AD-47F4BE3FB15D

P433

Q24235525-10D2143F-0FFB-45A5-A668-B3DDA6E282CB

P50

Q24235525-7B259356-60E6-49EF-A85C-379691706431

P577

Q24235525-C5C1072C-B73E-4B80-B1E2-92E1BADEB58B

P698

Q24235525-13FEF0A2-D7B2-4A42-8498-5F9584C5C04B

P932

Q24235525-12BEBAEC-58F1-4847-907E-A2A22A9A08E9

P356

14651858.CD008205.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

@en

P2093

Aleida Postma

http://www.w3.org/2001/XMLSchema#string

Bart Gp Koot

http://www.w3.org/2001/XMLSchema#string

Dorine Bresters

http://www.w3.org/2001/XMLSchema#string

Elvira C van Dalen

http://www.w3.org/2001/XMLSchema#string

Huib N Caron

http://www.w3.org/2001/XMLSchema#string

Leontien Cm Kremer

http://www.w3.org/2001/XMLSchema#string

Malon Van den Hof

http://www.w3.org/2001/XMLSchema#string

Piet N Post

http://www.w3.org/2001/XMLSchema#string

Renée L Mulder

http://www.w3.org/2001/XMLSchema#string

Sharon M Castellino

http://www.w3.org/2001/XMLSchema#string

P2860

Methotrexate hepatotoxicity in children with leukemia

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial

Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.

Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma.

6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.

Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection.

Hepatotoxicity of chemotherapy.

Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.

High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group.

P304

CD008205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD008205.PUB2

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21735424

http://www.w3.org/2001/XMLSchema#string

P932

6464972

http://www.w3.org/2001/XMLSchema#string